COMMUNIQUÉS West-GlobeNewswire

Best Cutting and Bulking Sarms 2025 - Fat Loss, Muscle Growth, Sarms Stack - Buy Sarms Online (Sarms For Sale) - Best Place to Buy Sarms - By CrazyBulk

21/04/2025 - 21:24

New York, April 21, 2025 (GLOBE NEWSWIRE) -- Considering cycles in the bodybuilding niche, the ultimate goal is to build lean muscle mass and eliminate excess fat. This is why, over time, SARMs have gained popularity; [...]

Anavar Steroid: Cycle, Dosage, Side Effects - Anavar for women (Anavar for Sale) - Buy Anavar 2025 (Before And After Anavar Result) - By CrazyBulk

21/04/2025 - 21:30

New York, April 21, 2025 (GLOBE NEWSWIRE) -- Anavar or oxandrolone, with its chemical name also being its common name, is a popular anabolic steroid among women athletes and bodybuilders. Women wanting muscle gain, fat [...]

Best Bulking & Cutting Steroids - Weight loss, Oral Steroid Stacks for Muscle Gain & Fat Loss and Huge size By CrazyBulk

21/04/2025 - 22:00

New York , April 21, 2025 (GLOBE NEWSWIRE) -- Bulking steroids will be on the mind of any bodybuilder when considering rapid muscle gain. This article delves deep into Crazybulk anabolic steroids for muscle growth— [...]

Design Therapeutics to Present Phase 1 Data for Fuchs Endothelial Corneal Dystrophy Program at Eyecelerator @ Park City 2025

21/04/2025 - 22:01

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]

Mindpeak and DigitCells Forge Alliance to Advance AI-Powered Digital Pathology Workflows: A Paradigm Shift for Diagnostic Precision and Efficiency

21/04/2025 - 16:27

DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force in artificial intelligence-driven pathology software, today announced a partnership. This strategic [...]

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

21/04/2025 - 17:19

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission to FDA Planned for [...]

LIPOZEM REVIEWS: How Reliable Is It? Investigation Completed 2025

21/04/2025 - 17:32

ST. PETERSBURG, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- Lipozem is an all-natural dietary supplement that uses only safe and natural components to promote healthy weight loss. With health and wellness taking center [...]

Happy Go Leafy Named Best Kratom Brand in On Pattison’s Latest Review

21/04/2025 - 19:00

On Pattison ranks Happy Go Leafy as the best Kratom brand in its latest review. How was the Assessment Done? What’s Next for HGL? Read more details. Miami. Florida, April 21, 2025 (GLOBE NEWSWIRE) -- In a recent [...]

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations

21/04/2025 - 13:05

ANN ARBOR, Mich., April 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, is pleased to provide an update on [...]

BioStem Technologies to Present at the Centri Capital Conference

21/04/2025 - 13:07

The presentation will be webcast at 10:30 AM ET on April 22, 2025 POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, [...]

Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders

21/04/2025 - 13:22

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and [...]

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

21/04/2025 - 13:30

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's [...]

Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences

21/04/2025 - 14:00

TEL AVIV, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd ., (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high [...]

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

21/04/2025 - 14:00

Proposed bipartisan legislation would expand Medicare reimbursement pathways for AI-enabled medical devices — a framework that supports Nexalin’s Gen-3 HALO Clarity™ neurostimulation device integrated with artificial [...]

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

21/04/2025 - 14:00

— Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic device (CIED) procedures — SILVER SPRING, Md., April 21, 2025 (GLOBE NEWSWIRE [...]

Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors

21/04/2025 - 14:00

MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

21/04/2025 - 14:00

GenesisX pairs clinical capability with broad accessibility in surgical robotics ST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally [...]

Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer

21/04/2025 - 14:00

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, announced the first [...]

ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat

21/04/2025 - 14:00

New “Decision to grant” communications in Europe and Japan MADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company [...]